Wells Fargo’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-98,679
| Closed | -$456K | – | 6820 |
|
|
2019
Q1 | $456K | Sell |
98,679
-4,241
| -4% | -$20.1K | ﹤0.01% | 4394 |
|
|
2018
Q4 | $360K | Buy |
102,920
+25,819
| +33% | +$179K | ﹤0.01% | 4544 |
|
|
2018
Q3 | $778K | Buy |
77,101
+20,100
| +35% | +$160K | ﹤0.01% | 4138 |
|
|
2018
Q2 | $413K | Buy |
57,001
+2,537
| +5% | +$17.7K | ﹤0.01% | 4600 |
|
|
2018
Q1 | $329K | Sell |
54,464
-2,556
| -4% | -$21.1K | ﹤0.01% | 4683 |
|
|
2017
Q4 | $549K | Buy |
57,020
+15,504
| +37% | +$101K | ﹤0.01% | 4323 |
|
|
2017
Q3 | $368K | Buy |
41,516
+13,849
| +50% | +$143K | ﹤0.01% | 4541 |
|
|
2017
Q2 | $350K | Buy |
27,667
+126
| +0.5% | +$1.49K | ﹤0.01% | 4443 |
|
|
2017
Q1 | $289K | Buy |
27,541
+6,407
| +30% | +$68.3K | ﹤0.01% | 4592 |
|
|
2016
Q4 | $195K | Sell |
21,134
-851
| -4% | -$9.61K | ﹤0.01% | 4796 |
|
|
2016
Q3 | $259K | Sell |
21,985
-1,377
| -6% | -$20.9K | ﹤0.01% | 4328 |
|
|
2016
Q2 | $302K | Sell |
23,362
-2,467
| -10% | -$36K | ﹤0.01% | 4180 |
|
|
2016
Q1 | $413K | Sell |
25,829
-1,049
| -4% | -$19.9K | ﹤0.01% | 3992 |
|
|
2015
Q4 | $770K | Sell |
26,878
-812,647
| -97% | -$22.5M | ﹤0.01% | 3646 |
|
|
2015
Q3 | $23.9M | Buy |
839,525
+694,864
| +480% | +$25.6M | 0.01% | 1178 |
|
|
2015
Q2 | $5.2M | Sell |
144,661
-175,473
| -55% | -$5.47M | ﹤0.01% | 2389 |
|
|
2015
Q1 | $9.3M | Sell |
320,134
-29,772
| -9% | -$787K | ﹤0.01% | 1938 |
|
|
2014
Q4 | $7.38M | Buy |
349,906
+124,632
| +55% | +$2.46M | ﹤0.01% | 2044 |
|
|
2014
Q3 | $4.37M | Buy |
225,274
+28,236
| +14% | +$443K | ﹤0.01% | 2416 |
|
|
2014
Q2 | $3.08M | Sell |
197,038
-28,948
| -13% | -$468K | ﹤0.01% | 2694 |
|
|
2014
Q1 | $4.68M | Buy |
225,986
+26,843
| +13% | +$532K | ﹤0.01% | 2366 |
|
|
2013
Q4 | $2.57M | Sell |
199,143
-113,598
| -36% | -$1.58M | ﹤0.01% | 2748 |
|
|
2013
Q3 | $3.65M | Sell |
312,741
-383,823
| -55% | -$3.15M | ﹤0.01% | 2420 |
|
|
2013
Q2 | $3.21M | Buy |
+696,564
| New | +$2.55M | ﹤0.01% | 2452 |
|
Other funds holding INSY
WS
Wells Fargo's INSY Position: Q2 2019 in Review
Wells Fargo sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 98,679 shares — an estimated $456K sold.
Wells Fargo first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $23.9M in Q3 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Wells Fargo reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Wells Fargo sold 98,679 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $456K.
- Wells Fargo first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
- Wells Fargo's Insys Therapeutics, Inc. position peaked at $23.9M in Q3 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Wells Fargo's 13F filing for Q2 2019, filed 6 Aug 2019.